$PLSE
Pulse Biosciences, Inc Common Stock (DE)
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
$44.68
▼-3.54%-$1.64
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePulse Biosciences, Inc Common Stock (DE)
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is PLSE down today? It is at $44.68 (-3.54%), and our scanner flagged it 81 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PLSE spikes, and full due diligence on PLSE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PLSE 81 times in the last 30 days. Create a free account to track $PLSE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PLSE from our scanner (live price and day move above). Fresh from the SEC: Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystPulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 14.3% of the tradeable float is in play - 14.3% more can still be issued.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
1,379,925 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $85.0M in size · Priced at $54.21/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Teplitsky Liane Rae Officer | Bought (open market) | +1K | added 32% | 4K | $50K at $49.95 | Sep 1, 26 |
Teplitsky Liane Rae Officer | Bought (open market) | +1K | added 49% | 3K | $50K at $48.80 | Aug 31, 26 |
Teplitsky Liane Rae Officer | Bought (open market) | +1K | added 100% | 2K | $50K at $48.35 | Aug 28, 26 |
Teplitsky Liane Rae Officer | Bought (open market) | +1K | n/a | 1K | $50K at $48.23 | Aug 26, 26 |
Duggan Robert W Director | Bought (open market) | +660K 0.9% of company | added 1.4% | 48.21M | $13.0M at $19.69 | May 11, 26 |
Laviolette Paul A Officer | Bought (open market) | +15K 0.02% of company | n/a | 15K | $295K at $19.69 | May 11, 26 |
Danahy Kevin Patrick Officer | Sold (automatic/other) | -5K | sold 10% | 43K | $118K at $23.64 | Feb 18, 26 |
Danahy Kevin Patrick Officer | Other | 5K | added 12% | 48K | $8K at $1.53 | Feb 18, 26 |
Danahy Kevin Patrick Officer | Sold (automatic/other) | -20K 0.03% of company | sold 32% | 43K | $473K at $23.63 | Feb 17, 26 |
Danahy Kevin Patrick Officer | Other | 20K 0.03% of company | added 46% | 63K | $31K at $1.53 | Feb 17, 26 |
Danahy Kevin Patrick Officer | Sold (automatic/other) | -20K 0.03% of company | sold 32% | 43K | $471K at $23.53 | Feb 13, 26 |
Danahy Kevin Patrick Officer | Other | 20K 0.03% of company | added 46% | 63K | $31K at $1.53 | Feb 13, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
Here is the latest on PLSE from our scanner (live price and day move above). Fresh from the SEC: Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center. A material company disclosure like this is often the real catalyst behind a move of this size.
PLSE last traded at $44.68, down 3.54% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Pulse Biosciences, Inc Common Stock (DE) (PLSE) is next expected to report earnings on Wednesday, November 4, 2026, about 20 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PLSE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PLSE 81 times in the last 30 days.
PLSE (Pulse Biosciences, Inc Common Stock (DE)) trades on XNAS, with a market cap of about $3.30B in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PLSE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PLSE discussion
Sign in to ask a question or join the discussion.